Reduced lecithin: Cholesterol acyltransferase (LCAT) and Na+,K+,ATPase activity in diabetic patients

Kiziltunc, A; Akcay, F; Polat, MUHAMMET; Kuskay, S; Sahin, YN

doi:10.1016/s0009-9120(96)00156-7

Reduced lecithin: Cholesterol acyltransferase (LCAT) and Na+,K+,ATPase activity in diabetic patients

Kiziltunc A., Akcay F., Polat F., Kuskay S., Sahin Y.

CLINICAL BIOCHEMISTRY, vol.30, no.2, pp.177-182, 1997 (SCI-Expanded, Scopus)

Publication Type: Article / Article
Volume: 30 Issue: 2
Publication Date: 1997
Doi Number: 10.1016/s0009-9120(96)00156-7
Journal Name: CLINICAL BIOCHEMISTRY
Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
Page Numbers: pp.177-182
Keywords: diabetes mellitus, Na+,K+,ATPase, lecithin, cholesterol acyltransferase, HIGH-DENSITY-LIPOPROTEINS, POTASSIUM ATPASE ACTIVITY, PERIPHERAL-NERVE, HUMAN-PLASMA, FATTY-ACIDS, INSULIN, MEMBRANE, IDENTIFICATION, SORBITOL, MELLITUS
Yozgat Bozok University Affiliated: Yes

Abstract

Objectives: To investigate the plasma concentrations of lecithin:cholesterol acyltransferase (LCAT EC 2.3.1.43) and erythrocyte membrane Na+,K+,ATPase and the correlation of these parameters in diabetes mellitus.